Kinetics

2

Review clinical trials related to Kinetics. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

"Balance, Gait, and Motion Analysis in Multiple Sclerosis"

The goal of this observational cross-sectional study is to investigate the relationship between functional measures of balance and gait and objective kinetic and kinematic parameters in people with Multiple Sclerosis (MS). The main questions it aims to answer are: i) What is the relationship between kinetic and kinematic gait and balance parameters measured using the Vicon motion analysis system and performance on clinical functional assessments in people with Multiple Sclerosis? ii) Which biomechanical parameters are most strongly associated with functional balance, gait, and physical performance outcomes? Participants will attend a single laboratory-based assessment session. During this session, they will undergo biomechanical gait and balance analysis using the Vicon motion capture system, complete functional assessments of balance, gait, and physical performance, complete questionnaires assessing fear of falling and fatigue, and undergo assessment of lower-limb spasticity.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of PatrasUpdated: Jun 24, 2026Locations: 2
Eligibility criteria

Adults (≥ 18 years) with confirmed diagnosis of Multiple Sclerosis [+4]

History of injury or surgical intervention to the lower limbs or spine within th... [+2]

Status: Recruiting

Bioavailability of Aronia Melanocarpa

The main objective of this study is to study the bioavailability and kinetics of acute Aronia Melanocarpa supplementation in healthy young (18-35 years) and older adults (55-75 years) adults. During the test day, participants will ingest a drink consisting of Aronia Melanocarpa extract (AME). The bioavailability and kinetics of AME will be assessed via frequent blood sampling, urine collection, and faecal sampling, in which AME and metabolite profiles will be quantified.

Participants needed: 16
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Maastricht University Medical CenterUpdated: Jun 13, 2024Locations: 1
Eligibility criteria

BMI between 18-35 kg/m2 [+3]

Smoking or smoking cessation < 12 months [+8]